ALNOV.PA
Novacyt SA
Price:  
0.48 
EUR
Volume:  
42,645.00
France | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ALNOV.PA Relative Valuation

-3871.4%
Upside

As of 2025-07-11, the Relative Valuation of Novacyt SA (ALNOV.PA) is (17.91) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.48 EUR, the upside of Novacyt SA based on Relative Valuation is -3871.4%.

The range of the Relative Valuation is (17.03) - (19.00) EUR.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 28.8x - 39.4x 33.8x
Forward P/E multiples 23.3x - 32.1x 26.8x
Fair Price (17.03) - (19.00) (17.91)
Upside -3684.7% - -4100.4% -3871.4%
0.48 EUR
Stock Price
(17.91) EUR
Fair Price

ALNOV.PA Relative Valuation - Historical P/E Data

Date P/E
2025-07-10 -0.80
2025-07-09 -0.80
2025-07-08 -0.79
2025-07-07 -0.81
2025-07-04 -0.81
2025-07-03 -0.83
2025-07-02 -0.83
2025-07-01 -0.84
2025-06-30 -0.83
2025-06-27 -0.83
2025-06-26 -0.81
2025-06-25 -0.80
2025-06-24 -0.83
2025-06-23 -0.83
2025-06-20 -0.85
2025-06-19 -0.85
2025-06-18 -0.85
2025-06-17 -0.85
2025-06-16 -0.85
2025-06-13 -0.90
2025-06-12 -0.98
2025-06-11 -0.95
2025-06-10 -0.96
2025-06-09 -0.94
2025-06-06 -0.93
2025-06-05 -0.92
2025-06-04 -0.95
2025-06-03 -0.92
2025-06-02 -0.96
2025-05-30 -0.97
2025-05-29 -0.98
2025-05-28 -0.92
2025-05-27 -0.98
2025-05-26 -1.22
2025-05-23 -0.90
2025-05-22 -0.77
2025-05-21 -0.80
2025-05-20 -0.78
2025-05-19 -0.79
2025-05-16 -0.76
2025-05-15 -0.78
2025-05-14 -0.79
2025-05-13 -0.80
2025-05-12 -0.79
2025-05-09 -0.77
2025-05-08 -0.77
2025-05-07 -0.76
2025-05-06 -0.75
2025-05-05 -0.75
2025-05-02 -0.76